No abstract available
Keywords:
Fcγ receptors; daratumumab; immunotherapy; multiple myeloma; polymorphisms.
Publication types
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antibodies, Monoclonal / administration & dosage*
-
Antibodies, Monoclonal / adverse effects
-
Disease-Free Survival
-
Female
-
Humans
-
Male
-
Multiple Myeloma* / drug therapy
-
Multiple Myeloma* / genetics
-
Multiple Myeloma* / mortality
-
Neoplasm Proteins / genetics*
-
Polymorphism, Genetic
-
Receptors, IgG / genetics*
-
Survival Rate
Substances
-
Antibodies, Monoclonal
-
FCGR2A protein, human
-
FCGR2B protein, human
-
Neoplasm Proteins
-
Receptors, IgG
-
daratumumab